Tumour-induced angiogenesis: A review

Journal of Theoretical Medicine

Volumn 5, Issue 3-4, 2003, Pages 137-153

  Plank, M J ^a   Sleeman, B D ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Angiogenesis; Invasion and metastasis; Tumour biology

Indexed keywords

ALPHA INTERFERON; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; BETA INTERFERON; CELL SURFACE RECEPTOR; COLLAGEN; ENDOSTATIN; FIBRONECTIN; GELATINASE B; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CHEMOKINESIS; DRUG DESIGN; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE MUTATION; HUMAN; METASTASIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR VASCULARIZATION;

EID: 10944254281     PISSN: 10273662     EISSN: None     Source Type: Journal    
DOI: 10.1080/10273360410001700843     Document Type: Review

References (110)

1. Acker, T., Beck, H. and Plate, K.H. (2001) "Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularisation", Mech. Dev. 108, 45-57.
2. Adatia, R., Poggi, L., Thompson, E.W., Gallo, R.C., Fassina, G.F. and Albini, A. (1992) "Assessment of angiogenic potential - the use of AIDS-KS cell supernatants as an in vitro model", In: Steiner, R., Weisz, P.B. and Langer, R., eds, Angiogenesis: Key Principles - Science - Technology - Medicine (Birkhauser Verlag, Basel), pp 321-326.
3. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K. and Watson, J.D. (1994) The Molecular Biology of the Cell, 3rd Ed. (Garland, New York).
4. Ashara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M., Magner, M., Yancopoulos, G.D. and Isner, J.M. (1998) "Tie-2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularisation", Circ. Res. 83, 233-240.
5. Auerbach, R., Lewis, R., Shinners, B., Kubai, L. and Akhtar, N. (2003) "Angiogenesis assays: a critical overview", Clin. Chem. 49, 32-40.
6. Ausprunk, D.H. and Folkman, J. (1977) "Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis", Microvasc. Res. 14, 53-65.
7. Benjamin, L.E., Hemo, I. and Keshet, E. (1998) "A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF", Development 125, 1591-1598.
8. Bikfalvi, A. (1995) "Significance of angiogenesis in tumour progression and metastasis", Eur. J. Cancer 31, 1101-1104.
9. Bingle, L., Brown, N.J. and Lewis, C.E. (2002) "The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies", J. Pathol. 196, 254-265.
10. Birdwell, C.R., Gospodarowicz, D. and Nicolson, G.L. (1978) "Identification, localisation and role of fibronectin in cultured bovine endothelial cells", Proc. Natl Acad. Sci. USA 75, 3273-3277.
11. Bökel, C. and Brown, N.H. (2002) "Integrins in development: moving on, responding to, and sticking to the extracellular matrix", Dev. Cell 3, 311-321.
12. Bowersox, J.C. and Sorgente, N. (1982) "Chemotaxis of aortic endothelial cells in response to fibronectin", Cancer Res. 42 2547-2551.
13. Burke, P.A. and DeNardo, S.J. (2001) "Antiangiogenic agents and their promising potential in combined therapy", Crit. Rev. Oncol. Haematol. 39, 155-171.
14. Cao, Y. (2001) "Endogenous angiogenesis inhibitors and their therapeutic implications", Int. J. Biochem. Cell Biol. 33, 357-369.
15. Carmeliet, P. (2000) "Mechanisms of angiogenesis and arteriogenesis", Nat. Med. 6, 389-395.
16. Carmeliet, P. and Jain, R.K. (2000) "Angiogenesis in cancer and other diseases", Nature 407, 249-257.
17. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J. and Moons, L. (1996) " Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele", Nature 380, 435-439.
18. Carter, S.B. (1965) "Principles of cell motility: the direction of cell movement and cancer invasion", Nature 208, 1183-1187.
19. Cavallaro, U. and Christofori, G. (2000) "Molecular mechanisms of tumour angiogenesis and tumour progression", J. Neuro-Oncol. 50, 63-70.
20. Claesson-Welsh, L., Welsh, M., Ito, N., Anand-Apte, B., Soker, S., Zetter, B., O'Reilly, M. and Folkman, J. (1998) " Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD", Proc. Natl Acad. Sci. USA 95, 5579-5583.
21. Dahlquist, F.W., Lovely, P. and Koshland, D.E. (1972) "Quantitative analysis of bacterial migration in chemotaxis", Nat. New Biol. 236, 120-123.
22. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C. and Yancopoulos, G.D. (1996) "Isolation of angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning" , Cell 87, 1161-1169.
23. Dvorak, H.F. and Gresser, I. (1989) "Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumours in mice", J. Natl Cancer Inst. 81, 497-502.
24. Ferrara, N. (2000) "Vascular endothelial growth factor and the regulation of angiogenesis", Recent Prog. Horm. Res. 55, 15-36.
25. Folkman, J. (1971) "Tumour angiogenesis: therapeutic implications", N. Engl. J. Med. 285, 1182-1186.
26. Folkman, J. and Hochberg, M. (1973) "Self-regulation of growth in three dimensions", J. Exp. Med. 138, 745-753.
27. Folkman, J. and Klagsbrun, M. (1987) "Angiogenic factors", Science 235, 442-447.
28. Gately, S., Twardowski, P., Stack, M.S., Patrick, M., Boggio, L., Cundiff, D.L., Schnaper, H.W., Madison, L., Volpert, O., Bouck, N., Enghild, J., Kwaan, H.C. and Soff, G.A. (1996) "Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin", Cancer Res. 56, 4887-4890.
29. Gately, S., Twardowski, P., Stack, M.S., Cundiff, D.L., Grella, D., Castellino, F.J., Enghild, J., Kwaan, H.C., Lee, F., Kramer, R.A., Volpert, O., Bouck, N. and Soff, G.A. (1997) "The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin", Proc. Natl Acad. Sci. USA 94, 10868-10872.
30. Good, D.J., Polverini, P.J., Rastinejad, F., LeBeau, M.M., Lemons, R.S., Frazier, W.A. and Bouck, N.P. (1990) "A tumour suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin", Proc. Natl Acad. Sci. USA 87, 6624-6628.
31. Han, Z.C. and Liu, Y. (1999) "Angiogenesis: state of the art", Int. J. Haematol. 70, 68-82.
32. Hanahan, D. (1997) "Signalling vascular morphogenesis and maintenance", Science 277, 48-50.
33. Hanahan, D. and Folkman, J. (1996) "Patterns and emerging mechanisms of the angiogenic switch during tumourigenesis", Cell 86, 353-364.
34. Harfouche, R., Hassessian, H.M., Guo, Y., Faivre, V., Srikant, C.B., Yancopoulos, G.D. and Hussain, S.N.A. (2002) " Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells", Microvasc. Res. 64, 135-147.
35. Hashizume, H., Baluk, P., Morikawa, S., McLean, J.W., Thurston, G., Roberge, S., Jain, R.K. and McDonald, D.M. (2000) "Openings between defective endothelial cells explain tumour vessel leakiness", Am. J. Pathol. 156, 1363-1380.
36. Hirschi, K.K. and D'Amore, P.A. (1996) "Pericytes in the microvasculature", Cardiovasc. Res. 32, 687-698.
37. Holash, J., Wiegand, S.J. and Yancopoulos, G.D. (1999) "New model of tumour angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF", Oncogene 18, 5356-5362.
38. Hunt, T.K., Knighton, D.R., Thakral, K.K., Goodson, W.H. and Andrews, W.S. (1984) "Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated macrophages", Surgery 96, 48-54.
39. Jiang, Y., Goldberg, I.D. and Shi, Y.E. (2002) "Complex roles of tissue inhibitors of metalloproteinases in cancer", Oncogene 21, 2245-2252.
40. Jones, P.F. (1997) "Tied up (or down?) with angiopoietins", Angiogenesis 1, 38-44.
41. Kim Lee Sim, B., MacDonald, N.J. and Gubish, E.R. (2000) "Angiostatin and endostatin: endogenous inhibitors of tumour growth", Cancer Metastasis Rev. 19, 181-190.
42. King, R.J.B. (1996) Cancer Biology (Longman, Essex).
43. Kirsch, M., Schackert, G. and Black, P.M. (2000) "Angiogenesis, metastasis and endogenous inhibition", J. Neuro-Oncol. 50, 173-180.
44. Klagsbrun, M. and D'Amore, P.A. (1996) "Vascular endothelial growth factor and its receptors", Cytokine Growth Factor Rev. 7 259-270.
45. Koblizek, T.I., Weiss, C., Yancopoulos, G.D., Deutsch, U. and Risau, W. (1998) "Angiopoietin-1 induces sprouting angiogenesis in vitro", Curr Biol. 8, 529-532.
46. Kraling, B.M., Wiederschain, D.G., Boehm, T., Rehn, M., Mulliken, J.B. and Moses, M.A. (1999) "The role of matrix metalloprotease activity in the maturation of human capillary endothelial cells in vitro", J. Cell Sci. 112, 1599-1609.
47. Kubo, H., Cao, R., Bräkenhielm, E., Mäkinen, T., Cao, Y. and Alitalo, K. (2002) "Blockade of vascular endothelial growth factor receptor-3 signalling inhibits fibroblast growth factor-2 induced lymphangiogenesis", Proc. Natl Acad. Sci. USA 99, 8868-8873.
48. Lauffenburger, D.A. and Zigmond, S.H. (1981) "Chemotactic factor concentration gradients in chemotaxis assay systems", J. Immunol. Methods 40, 45-60.
49. Lauren, J., Gunji, Y. and Alitalo, K. (1998) "Is angiopoietin-2 necessary for the initiation of tumour angiogenesis?" , Am. J. Pathol. 153, 1333-1339.
50. Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V. and Ferrara, N. (1989) "Vascular endothelial growth factor is a secreted angiogenic mitogen", Science 246, 1306-1309.
51. Liotta, L.A., Rao, C.N. and Sanford, H.B. (1983) "Tumour invasion and the extracellular matrix", Lab. Investig. 49, 636-649.
52. Liotta, L.A., Steeg, P.S. and Steder-Stevenson, W.G. (1991) "Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation", Cell 64, 327-336.
53. Liu, W., Ahmad, S.A., Reinmuth, N., Shaheen, R.M., Jung, Y.D., Fan, F. and Ellis, L.M. (2000) "Endothelial cell survival and apoptosis in the tumour vasculature", Apoptosis 5, 323-328.
54. Lobov, I.B., Brooks, P.C. and Lang, R.A. (2002) "Angiopoietin-2 displays vascular endothelial growth factor-dependent modulation of capillary structure and endothelial cell survival in vivo", Proc. Natl Acad. Sci. USA 99, 11205-11210.
55. Loughna, S. and Sato, T.N. (2001) "Angiopoietin and Tie signalling pathways in vascular development", Matrix Biol. 20 319-325.
56. Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandriota, S.J., Borlat, F., Sim, B.K.L., Wu, Z., Grau, G.E., Shing, Y., Soff, G.A., Bouck, N. and Pepper, M.S. (1998) "Multiple forms of angiostatin induce apoptosis in endothelial cells", Blood 92, 4730-4741.
57. Maier, J.A.M., Morelli, D., Lazzerini, D., Menard, S., Colnaghi, M.I. and Balsari, A. (1999) "Inhibition of fibronectin-activated migration of microvascular endothelial cells by interleukin-1α, tumour necrosis factor-α and interferon-γ", Cytokine 11, 134-139.
58. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papandopoulos, N., Daly, T.J., Davis, S. and Sato, T.N. (1997) "Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis", Science 277, 55-60.
59. Mandriota, S.J., Menoud, P.A. and Pepper, M.S. (1996) "Transforming growth factor-β1 down-regulates vascular endothelial growth factor receptor-2/Flk-1 expression in vascular endothelial cells", J. Biol. Chem. 271, 11500-11505.
60. McCarthy, J.B. and Furcht, L.T. (1984) "Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro", J. Cell Biol. 98, 1474-1480.
61. McDonald, D.M. and Foss, A.J.E. (2000) "Endothelial cells of tumour vessels: abnormal but not absent", Canc. Metastasis Rev. 19, 109-120.
62. Moser, T.L., Stack, M.S., Wahl, M.L. and Pizzo, S.V. (2002) "The mechanism of action of angiostatin: can you teach an old dog new tricks?", Thromb. Haemostasis 87, 394-401.
63. Muthukkaruppan, V.R. and Auerbach, R. (1979) "Angiogenesis in the mouse cornea", Science 205, 1416-1418.
64. Muthukkaruppan, V.R., Kubai, L. and Auerbach, R. (1982) "Tumour-induced neovascularisation in the mouse eye", J. Natl Cancer Inst. 69, 699-708.
65. Nicosia, R.F., Bonanno, E. and Smith, M. (1993) "Fibronectin promotes the elongation of microvessels during angiogenesis in vitro :, J. Cell Physiol. 154, 654-661.
66. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H. and Folkman, J. (1994) "Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma", Cell 79 315-328.
67. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olsen, B.R. and Folkman, J. (1997) "Endostatin: an endogenous inhibitor of angiogenesis and tumour growth", Cell 88, 277-285.
68. Oh, H., Takagi, H., Suzuma, K., Otani, A., Matsumura, M. and Honda, Y. (1999) "Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells", J. Biol. Chem. 274, 15732-15739.
69. Papetti, M. and Herman, I.M. (2002) "Mechanisms of normal and tumour-derived angiogenesis", Am. J. Physiol. Cell Physiol. 282, C947-C970.
70. Patan, S. (2000) "Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodelling", J. Neuro-Oncol. 50, 1-15.
71. Paweletz, N. and Kneirim, M. (1989) "Tumour-related angiogenesis", Crit. Rev. Oncol. Haematol. 9, 197-242.
72. Pepper, M.S. (1997) "Manipulating angiogenesis", Arterio. Thromb. Vasc. Biol. 17, 605-619.
73. Pepper, M.S. (2001) "Extracellular proteolysis and angiogenesis", Thromb. Haemostasis 86, 346-355.
74. Pepper, M.S., Belin, D., Montesano, R., Orci, L. and Vassalli, J.D. (1990) "Transforming growth factor-β1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro", J. Cell Biol. 111, 743-755.
75. Pepper, M.S., Bassalli, J.D., Orci, L. and Montesano, R. (1992) "Proteolytic balance and capillary morphogenesis in vitro :, In: Steiner, R., Weisz, P.B. and Langer, R., eds, Angiogenesis: Key Principles-Science-Technology-Medicine (Birkhauser Verlag, Basel), pp 137-145.
76. Pozzi, A., LeVine, W.F. and Gardner, H.A. (2002) "Low plasma levels of matrix metalloproteinase-9 permit increased tumour angiogenesis", Oncogene 21, 272-281.
77. Presta, M., Rusnati, M., Urbinati, C., Tanghetti, E., Statuto, M., Pozzi, A., Gualandris, A. and Ragnotti, G. (1992) " Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells", In: Steiner, R., Weisz, P.B. and Langer, R., eds, Angiogenesis: Key Principles-Science-Technology-Medicine (Birkhauser Verlag, Basel), pp 205-209.
78. Ramsauer, M. and D'Amore, P.A. (2002) "Getting Tie(2)d up in angiogenesis", J. Clin. Investig. 110, 1615-1617.
79. Reynolds, L.P., Killilea, S.D. and Redmer, D.A. (1992) "Angiogenesis in the female reproductive cycle", FASEB J. 6 886-892.
80. Risau, V. (1997) "Mechanisms of angiogenesis", Nature 386, 671-674.
81. Rosen, L.S. (2002) "Clinical experience with angiogenesis signalling inhibitors: focus on vascular endothelial growth factor blockers", Cancer Control 9, 36-44.
82. Rupp, P.A. and Little, C.D. (2001) "Integrins in vascular development", Circ. Res. 89, 566-572.
83. Saaristo, A., Karpanen, T. and Alitalo, K. (2000) "Mechanisms of angiogenesis and their use in the inhibition of tumour growth and metastasis", Oncogene 19, 6122-6129.
84. Santini, M.T., Rainaldi, G. and Indovina, P.L. (2000) "Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumour spheroids", Crit. Rev. Oncol. Haematol. 36, 75-87.
85. Schirrmacher, V. (1985) "Cancer metastasis: experimental approaches, theoretical concepts and impacts for treatment strategies", Adv. Cancer Res. 43, 1-73.
86. 1 integrins", Proc. Natl Acad. Sci. USA 94, 13612-13617.
87. Sharp, P.S. (1995) "The role of growth factors in the development of diabetic retinopathy", Metabolismo 44(Suppl. 4), 72-75.
88. Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J. and Klagsbrun, M. (1984) "Heparin affinity: purification of a tumour-derived capillary endothelial cell growth factor", Science 223, 1296-1299.
89. Sholley, M.M., Ferguson, G.P., Seibel, H.R., Montour, J.L. and Wilson, J.D. (1984) "Mechanisms of neovascularisation", Lab. Investig. 51, 624-634.
90. Shweiki, D., Itin, A., Soffer, D. and Keshet, E. (1992) "Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis", Nature 359, 843-845.
91. Soff, G.A. (2000) "Angiostatin and angiostatin-related proteins", Cancer Metastasis Rev. 19, 97-107.
92. Stack, M.S., Gately, S., Bafetti, L.M., Enghild, J.J. and Soff, G.A. (1999) "Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation", Biochem. J. 340, 77-84.
93. Stratmann, A., Risau, W. and Plate, K.H. (1998) "Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis", Am. J. Pathol. 153, 1459-1466.
94. Sundberg, C., Kowanetz, M., Brown, L.F., Detmar, M. and Dvorak, H.F. (2002) "Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo", Lab. Investig., 82, 387-401.
95. Suri, C., Jones, P.F. Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996) "Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis", Cell 87, 1171-1180.
96. Sutherland, R.M. (1986) "Importance of critical metabolites and cellular interactions in the biology of microregions of tumours" , Cancer 58, 1668-1680.
97. Sutherland, R.M. (1988) "Cell and environment interactions in tumour microregions: the multicell spheroid model", Science 240, 177-184.
98. Thurston, G. (2002) "Complementary actions of vascular endothelial growth factor and angiopoietin-1 on blood vessel growth and leakage", J. Anat. 200, 575-580.
99. Thurston, G., Rudge, J.S., Ioffe, E., Zhou, H., Ross, L., Croll, S.D., Glazer, N., Holash, J., McDonald, D.M. and Yancopoulos, G.D. (2000) "Angiopoietin-1 protects the adult vasculature against plasma leakage", Nature Med. 6, 460-463.
100. Uemura, A., Ogawa, M., Hirashima, M., Fujiwara, T., Koyama, S., Takagi, H., Honda, Y., Wiegand, S.J., Yancopoulos, G.D. and Nishikawa, S.I. (2002) "Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells", J. Clin. Investig. 110, 1619-1628.
101. Vajkoczy, P., Farhadi, M., Gaumann, A., Heidenreich, R., Erber, R., Wunder, A., Tonn, J.C., Menger, M.D. and Breier, G. (2002) "Microtumour growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2 and angiopoietin-2", J. Clin. Investig. 109, 777-785.
102. Vernon, R.B. and Sage, E.H. (1999) "A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices", Microvasc. Res. 57, 118-133.
103. Vihinen, P. and Kahari, V (2002) "Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets", Int. J. Cancer 99, 157-166.
104. Walsh, D.A. (1999) "Angiogenesis and arthritis", Rheumatology 38, 103-112.
105. Witzenbichler, B., Maisonpierre, P.C., Jones, P., Yancopoulos, G.D. and Isner, J.M. (1998) "Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelialspecific receptor tyrosine kinase Tie-2", J. Biol. Chem. 273, 18514-18521.
106. Wright, T.J., Leach, L., Shaw, P.E. and Jones, P. (2002) "Dynamics of vascular endothelial-cadherin and β-catenin localisation by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells", Exp. Cell. Res. 280, 159-168.
107. Yamada, K.M. and Olden, K. (1978) "Fibronectins - adhesive glycoproteins of cell surface and blood", Nature 275, 179-184.
108. Yancopoulos, G.D., Davis, S., Gale, N.W., Rudge, J.S., Wiegand, S.J. and Holash, J. (2000) "Vascular-specific growth factors and blood vessel formation", Nature 407, 242-249.
109. Yuan, H.T., Yang, S.P. and Woolf, A.S. (2000) "Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells", Kidney Int. 58, 1912-1919.
110. Zagzag, D., Hooper, A., Friedlander, D.R., Chan, W., Holash, J., Wiegand, S.J., Yancopoulos, G.D. and Grumet, M. (1999) "In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumour angiogenesis", Exp. Neurol. 159 391-400.